期刊文献+

58例隐匿型肾癌临床诊疗分析 被引量:1

原文传递
导出
摘要 目的 探讨隐匿型肾癌的临床特征、早期诊治情况及对预后的影响.方法 回顾性分析58例隐匿型肾癌患者的临床资料.结果 58例中男38例,女20例,平均年龄57.5岁.体检或因其他部位不适在检查过程中偶然发现者40例(68.9%),无痛性血尿10例,腰背部疼痛6例(10.3%),因慢性肾功能不全,经B超、CT检查发现2例.临床分期为T_1N_0M_037例,T_2N_0M_016例,T3期以上5例.行肾癌根治性切除术57例.术后接受α-干扰素和白介素-2治疗21例.随访58例,平均随访时间48个月.结论 提高诊断意识是关键,彩色多普勒超声、CT是目前早期诊断肾癌的重要手段;早期行根治性切除术是最有效的治疗方法.
作者 季宏斌
出处 《医学新知》 CAS 2010年第6期609-610,共2页 New Medicine
  • 相关文献

参考文献10

  • 1Naito S,Tomita Y.Kidney Cancer Working Group report[J].Jpn J Clin Oncol,2010,40(Suppl 1):i51-56.
  • 2Corenhour K,Struess M.Occult tumor embolization detected by intraoperative ransesophageal echocardiography[J].J Cardiothorac Vase Anesth,2009,23(1):77-78.
  • 3Richstone L,Scherr D S.Multifocal renal cortical tumors:frequency,associated clinicopathological features and impact on survival[J].J Urol,2004,171(2 Pt 1):615-620.
  • 4Stem Padovan B,Perkov D.Venous spread of renal cell carcinoma:MDCT[J].Abdom Imaging,2007,32(4):530-537.
  • 5Tanaka N,Fujimoto K.Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma[J].Urology,2004,64(5):904-908.
  • 6Cohenpour M,Strauss S.Pseudoananrysm of the renal artery following partial nephrectomy:imaging timings and coil embolization[J].Clin Radiol,2007,62(11):1104-1109.
  • 7Smith A D,Shah S N.Morphology,Attenuation,Size,and Structure (MASS)criteria:assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy[J].AJR Am J Roentgenol,2010,194(6):1470-1478.
  • 8Madbouly K,AI-Qahtani S M.Microvascular tumor invasion:prognostic significance in low-stage renal cell carcinoma[J].Urology,2007,69(4):670-674.
  • 9Geenen M M,Bakker P J.Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblaatic leukemia and Wilms tumor treated with radiotherapy[J].Pediatr Blood Cancer,2010,55(4):690-697.
  • 10沈海波,叶敏,王伟明,张良,陈方.肾癌根治术后免疫化疗的远期疗效观察[J].临床泌尿外科杂志,2005,20(1):4-5. 被引量:3

二级参考文献6

  • 1Vogelzang N J,Stadler W M.Kidney cancer.Lancet.1998.352:169l—1696.
  • 2Hofmockel G,I.anger W.Theiss M.ct a1.Immunochemotherapy for metastatic renal cell carcinoma using a regiment of interleukin-2.interferon-αand 5-fluorouracil.J Urol,1996.156:18—21.
  • 3Alzpodien J.Kirchncr H.Illiger H J.et a1.IL-2 in combination with IFN—alpha and 5-FU versc tamoxifcn in metastatic renal cell carcinoma:long—tcrm resuhs of a radomized clinical trial.Br J Canccr.2001.85:1130-1136.
  • 4Pyrhonen S,Salminen E,Ruutu M.et a1.Prospcctivc randomized trial of interferon alfa-2α pitls vinblastinc versus vinblastine alone in patients with advanccd rcnalcell cancer.J Clin Oncol.1999,17:2859—2867.
  • 5马建辉,鲍镇美.干扰素治疗肾癌[J].中华泌尿外科杂志,2003,24(6):429-431. 被引量:17
  • 6邱建宏.大剂量免疫化疗预防肾癌复发和转移的临床研究[J].中华泌尿外科杂志,2004,25(5):303-305. 被引量:9

共引文献2

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部